baber/WOPTO huggingface dataset:
Patent NZ-280108-A (NZ)
Title: Plastic reaction tube holder with removable perforated tray
Inventor: GRIFFEN REGINALD
IPC: C12Q1/68
Filed: 1995-09-27
Abstract: The plastics holder assembly includes a tray having a number of holes for receiving the tubes and having opposite vertical end walls, each of which have two spaced vertically extending slots and a horizontally extending recess between the slots. A retainer is releasably nestable in the tray having a corresponding number of holes and having opposite vertical end walls corresponding to the end walls of the tray. A U-shaped handle extends horizontally outwardly from each of the opposite retainer end walls, each handle having two legs which slide into the tray slots respectively when the retainer is nested in the tray. There is a tab projecting horizontally outwardly from each of the retainer end walls between each of the two legs which snap into the tray end wall recesses respectively when the retainer is nested in the tray. The retainer has an elongated slot parallel and directly adjacent each of the end walls, whereby inwardly directed finger pressure on the U-shaped handles inwardly flex the opposite ends of the retainer to release the tabs from the tray recesses respectively to facilitate removal of the retainer from the tray.
Patent NZ-286915-A (NZ)
Title: Protein with one or more antigenic determinants of eimeria lactate dehydrogenase, its production and use
Inventor: KOK JACOBUS JOHANNES
IPC: C12N15/09
Filed: 1996-07-01
Abstract: This invention relates to novel Eimeria proteins with immunogenic properties, and having lactate dehydrogendse activity as well as to DNA sequences encoding these proteins. These proteins can be administered to poultry thereby protecting the birds against coccidiosis. In addition the DNA encoding these proteins can be used for the preparation of a vector vaccine against coccidiosis.
Patent NZ-333876-A (NZ)
Title: Disinfecting water at a ph of 9-10 using iodine species comprising hypoiodous acid and iodine in aqueous solution
Inventor: HARVEY WAYNE A
IPC: C02F1/50
Filed: 1997-08-15
Abstract: A water treatment system and apparatus for producing bacteria- and virus-free water from a bacteria and virus-containing water supply, said apparatus comprising (a) generator means for holding solid elemental iodine and to allow solubilization of said iodine under dynamic aqueous flow; (b) means for feeding a first portion of said water supply to said generator means to produce an aqueous concentrated iodine solution; (c) means for providing a second portion of said water supply; (d) means for providing said aqueous concentrated iodine solution to said second portion of said water supply to provide a blended water supply; (e) storage means for holding said blended water supply to provide said bacteria- and virus-free water; (f) means for measuring water flow of said first and said second portions; (g) means for measuring the pH of said second portion; (h) means for adjusting the pH of said second portion; (i) means for measuring the temperature of said concentrated aqueous solution; and (j) control means for receiving flow data, pH data and temperature data from said means for measuring flow of said first and said second portions, said means for measuring pH of said second portion; said means for measuring temperature of said concentrated aqueous solution and means for adjusting pH of said second portion. The system provides an efficacious way of killing virus under the guidelines and standards set by the USEPA.
Patent NZ-336028-A (NZ)
Title: Substituted 4-amino-piperidine and pyrrolidine derivatives having an analgesic effect
Inventor: PELCMAN BENJAMIN
IPC: A61K31/00
Filed: 1997-12-09
Abstract: A substituted 4-amino-piperidine or pyrrolidine derivative or a pharmaceutically acceptable salt, isomer, hydrate, isoform or prodrug thereof has the formula (I) wherein: m is 0 or 1; n is 1 or 2; R1 is hydrogen, alkyl, cycloalkyl, alkyl cycloalkyl, benzyl, -(CH2)a-CH=CH2, -(CH2)a-G or a group of formyl (2) or optionally substituted aryl or a 5 to 10 membered heteroaryl having any of C, S, N and O; G is a 5 or 6 membered hydroaromatic or a heteroaromatic group where the heteroatoms are selected from O, S and N; a is 0 or 1; A is a group of formula (3) R6 to R18 are independently as defined for R1 above; Z1 and Z2 are defined in the specification; B is an optionally substituted 5 to 10 membered aromatic, heteroaromatic, hydroaromatic or heterohydroaromatic moiety having any of C, S, N and O. A diagnostic agent thereof and a pharmaceutical composition thereof useful for treating gastrointestinal disorders, spinal injuries and pain are disclosed.
Patent NZ-338007-A (NZ)
Title: Spiro condensed piperidine compounds useful for inhibiting nitric oxide synthase
Inventor: HAMLEY PETER
IPC: G06Q10/10
Filed: 1998-04-07
Abstract: A compound of formula (I) wherein: A represents a benzo ring, a six membered heterocyclic aromatic ring having 1 to 3 nitrogen atoms, or a five membered heterocyclic aromatic ring having 1 to 3 heteroatoms which may be the same or different and are selected from O, N and S; R2 and R3 independently represent hydrogen, alkyl, alkoxy, alkylthio, halogen, hydroxy or amino; R1 represents: (i) phenyl, a six membered heterocyclic aromatic ring having 1 to 3 nitrogen atoms, or a five membered heterocyclic aromatic ring having 1 to 3 heteroatoms which may be the same or different and are selected from O, N and S, the phenyl or heterocyclic aromatic ring being unsubstituted or substituted by alkyl, alkoxy, alkylthio, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, alkylthioalkyl, amino, halogen, hydroxy, cyano or nitro; or (ii) OR4, where R4 represents alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, alkylthioalkyl, arylalkyl or aryloxyalkyl; X represents CH2, CO, O or S(O)n where n represents an integer from 0 to 2; or a pharmaceutically acceptable salt, enantiomer or tautomer thereof. The compounds are useful for treating or reducing the risk of human diseases or conditions in which inhibition of nitric oxide synthase activity, including asthma or rheumatoid arthritis.
Patent NZ-500944-A (NZ)
Title: Fungicidal mixture comprising a carbamate and a fosetyl derivative
Inventor: MULLER BERND
IPC: A01N47/24
Filed: 1998-05-15
Abstract: A fungicidal composition, comprising synergistically effective amounts of a carbamate of formula I and an active compound of formula II. In formula I: T is CH or N, n is 0, 1 or 2 and R is halogen, C1-C4-alkyl or C1-C4-halo-alkyl, wherein the radicals R are identical or different when n is 2. In formula II: Y is hydrogen, a metal atom of the 1st to 3rd main group of the Periodic Table of the Elements or a group NR3R4R5R6; R2 is hydrogen, a C1-C18-alkyl group which may be substituted by halogen or a nitro group, a C2-C8-alkenyl or C2-C8-alkinyl group each of which may be substituted by halogen or a nitro group, a C1-C8-alkoxy-C1-C8-alkyl or a C2-C8-alkenyl-C1-C8-alkyl group, an unsubstituted or substituted aryl group having 6 to 14 carbons, a C3-C7-cycloalkyl group, a C1-C4-alkylaryl group or a heterocyclic group having 5 or 6 ring atoms and a hetero atom from the group consisting of N, O and S, where the heterocyclic group is attached directly or via an aliphatic chain to the oxygen atom, and R3-R6 independently of one another are each a C1-C4-alkyl group or a C1-C4-hydroxyalkyl group.
Patent NZ-503520-A (NZ)
Title: Heteroaryl or aryl substituted diazacycloalkanes useful as cholinergic ligands at nicotinic acetylcholine receptors
Inventor: PETERS DAN
IPC: C07D417/04
Filed: 1998-10-27
Abstract: A homopiperazine derivative or an enantiomers or any mixture thereof, isotopes thereof or a pharmaceutically acceptable salt thereof has the formula (I) wherein: R is hydrogen, alkyl or benzyl and R1 is aminophenyl, nitrophenyl, hydroxyphenyl, alkoxyphenyl or optionally substituted pyridyl, pyridazinyl, pyranzinyl, quinolinyl or isoquinolinyl group. A pharmaceutical composition thereof is useful for treating a disease responsive to the activity of nicotinic acetylcholine receptors modulators.
Patent NZ-505088-A (NZ)
Title: Aqueous insecticidal pour-on formulation; comprising insect growth regulator (IGR), surfactant, suspending agent and aqueous carrier
Inventor: SHEPHERD STANLEY
IPC: A61K9/10
Filed: 1998-12-18
Abstract: A topically acceptable aqueous pour-on formulation adapted for localized external application to an animal, which formulation includes an effective amount of a water insoluble insect growth regulator (IGR), a suspending agent, a surfactant or mixture of surfactants and an aqueous carrier.
Patent NZ-507014-A (NZ)
Title: A gene encoding a novel marker for cancer
Inventor: MORRIS ARTHUR SHERMAN
IPC: H01F17/04
Filed: 1998-03-18
Abstract: A cDNA molecule that encodes a protein designated Labyrinthin (Lab) is isolated and its nucleotide sequence is determined. The protein, or peptides derived from the protein, are markers useful to define novel classes of cancers. Diagnostic assays for these cancers use antibodies to Lab or nucleotide probes that hybridise with the lab gene or a fragment therefrom. Vaccines useful either to prevent recurrence of cancers in subjects who test positive for Lab (or lab), or to prevent initial occurrence of cancer, use proteins or peptides derived from Lab. Expression of Lab via immunogenic assays is used to monitor effects of cancer treatments. Antisense molecules against lab are used in treatments. Sense molecules of lab are used to restore lost lab function in diseased normal cells, for example, gland cells.
Patent NZ-507846-A (NZ)
Title: Corner joint for trim or molding
Inventor: QUISKAMP GUENTER
IPC: E06B3/96
Filed: 2000-10-27
Abstract: A corner element for joining skirting boards at a corner has a first receptacle 12 for receiving an end of a skirting board, a second receptacle 14 to receive the end of the other skirting board to interconnect the skirting boards at an angle. The structural integrity of the corner element is ensured by a front wall 16, a rear wall 18, and adjoining wall 19 common to both receptacles.
Patent NZ-513667-A (NZ)
Title: Kit for radiolabeling proteins with yttrium-90
Inventor: CHINN PAUL
IPC: C07B59/00
Filed: 2000-02-29
Abstract: Methods and kits for radiolabeling proteins and peptides with radiolytic isotopes, particularly yttrium-90, are disclosed, whereby sufficient purity, specific activity and binding affinity are achieved such that the radiolabeled protein may be directly administered to a patient without further column purification. Such kits and methods will be particularly useful in bringing radioimmunotherapy to the hospital and outpatient setting for the treatment of cancer.
Patent NZ-523975-A (NZ)
Title: Animal papilla disinfectants and method of improving microbial environment comprising use of a microorganism of genus Brachybacterium
Inventor: ITO NAOKI
IPC: A61K35/74
Filed: 2001-08-10
Abstract: Disclosed is a disinfectant comprising a microorganism of the genus Brachybacterium. Such compositions are suitable for disinfecting animal teats and improving a microorganism environment harmful for animals. The composition may be sprayed into the environment, may be in a cloth or paper veil for covering an animal, or on paper or cloth placed into the animals environment.
Patent NZ-524911-A (NZ)
Title: Process and device for carrying out reactions in a reactor with slot-shaped reaction spaces
Inventor: SCHUTTE RUDIGER
IPC: B01F13/00
Filed: 2001-08-02
Abstract: Reactions between at least two fluid reactants are performed in a reactor comprising wall elements (1), slot- shaped reaction spaces (3) and cavities (5) for conducting a fluid heat-carrier through. Depending on the process and throughput, a modular structural design is chosen wherein an arbitrary number of wall elements (1) are assembled to a right-parallelepipedal block (24), the reaction spaces (3) are formed between lateral surfaces (2) of right- parallelepipedal wall elements (1), the reactants are introduced into the reaction spaces (3) from edge regions of one side of the block (24) and are conducted through the reaction spaces (3) in parallel flows and the fluid heat- carrier is conducted through the tubular cavities (5) extending in the interior of the wall elements (1).
Patent NZ-526198-A (NZ)
Title: Fixed OFDM wireless MAN utilizing CPE having internal antenna, with base stations communicating with general CPE
Inventor: GRINDAHL MERV
IPC: H04W99/00
Filed: 2000-10-23
Abstract: A wireless access system, comprising a plurality of base station units, wherein said base station units are arranged according to a cellular structure and wherein each of said plurality of base station units is connectable to a network, and a customer premise equipment (CPE) unit, wherein said CPE unit communicates with said a least one of said plurality of base station units via radio frequency and is connectable to a host, wherein upon connection of said CPE unit to said host said CPE unit learns a high-level internet protocol address and a low-level physical address of said host by observing communication traffic of said host. (62) Divided out of 518729
Patent NZ-526303-A (NZ)
Title: An improved stabiliser leg
Inventor: SUCKLING PETER ANDREW
IPC: B66C23/78
Filed: 2001-12-19
Abstract: A stabiliser leg including a housing pivotally mounted on   a  vehicle  with  an  extension  member  telescopically mounted  upon  the housing, a first hydraulic  cylinder  for controlling  the  angle  of  the  housing  relative  to  the vehicle,  and  a  second hydraulic cylinder for  controlling the  extension  of the extension member; an ankle  pivotally secured to the lower end of the extension member, such  that the  ankle  can  be  pivoted between a storage  position  in which  its  longitudinal axis is substantially perpendicular to  that of the extension member, and an in use position  in which  its  longitudinal axis is aligned with  that  of  the extension  member;  also including  means  for  locking  the ankle  in  the in use position without the use  of  a  third hydraulic  cylinder,  and a ground engaging  foot  which  is pivotally secured to the lower end of the ankle.
Patent NZ-526737-A (NZ)
Title: Gene encoding acetolactic acid synthase gene
Inventor: SHIMIZU TSUTOMU
IPC: C12N15/82
Filed: 2001-11-16
Abstract: A gene encoding an acetolactate synthase (ALS protein), which shows an extremely high resistance against PC-based herbicides is described. Namely, a gene which encodes the following protein (a) or (b). (a) A protein comprising the amino acid sequence represented by SEQ ID NO:1. (b) A protein comprising an amino acid sequence derived from the amino acid sequence represented by SEQ ID NO:1 by substitution, deletion or addition of at least one amino acid and having a resistance against pyrimidinylcarboxy-based herbicides and having an acetolactic acid synthase activity.
Patent NZ-531156-A (NZ)
Title: A method of manufacturing structural units
Inventor: VAN ERP GERARDUS MARIA
IPC: E04C3/28
Filed: 2002-08-13
Abstract: A method of producing an improved structural unit with anisotropic load characteristics, said method including the steps of producing a multiplicity of first building elements that are constructed from fibre-reinforced plastics material; producing at least one second building element that is of a different material to said first building elements; and adhering said first and second building elements together to form the improved structural unit.
Patent NZ-535334-A (NZ)
Title: Methods for preventing or treating cardiac arrhythmia
Inventor: BROWN ARTHUR M
IPC: A61P9/06
Filed: 2003-02-21
Abstract: A method of modulating the activity of an ion channel of mammalian cell used for preventing or treating cardiac arrhythmia, that comprises contacting a mammalian cell with an effective amount of vanoxerine, or pharmaceutically acceptable salt, derivative or metabolite thereof.
Patent NZ-535348-A (NZ)
Title: Heating system for liquids having a burner and finned heat exchanger filled with liquid
Inventor: SMITH DOUGLAS W
IPC: F24H1/30
Filed: 2003-02-11
Abstract: A heater for heating liquids comprises: (a) A housing having a base and an upper exhaust end for forming a plenum which conducts a flow of hot flue gas from a burner positioned adjacent to the housing's base; (b) A heat transfer vessel having a substantially conical body with a closed tip and a closed top, the body residing substantially coaxially within the plenum so as to form an annular space through which hot flue gases upwardly flow to the exhaust end, the tip of the body being orientated closest to the burner and having side walls diverging upwardly towards the plenum's exhaust end; (c) A vessel inlet adjacent to the top of the conical body for the entry of liquid to the vessel; (d) A vessel outlet adjacent to the tip of the conical body so that the liquid flows downwardly and countercurrent to the hot flue gas and is heated before being discharged from the vessel; and (e) One or more annular plates located transverse across the annular space for at least partially distributing the hot flue gas about the vessel as they pass upwardly by the one or more annular plates.
Patent NZ-535557-A (NZ)
Title: In situ recovery from a hydrocarbon containing formation
Inventor: BERCHENKO ILYA EMIL
IPC: E21B43/24
Filed: 2001-04-24
Abstract: Disclosed is a method of treating a hydrocarbon containing formation in situ comprising: Providing heat from one or more heat sources to at least a portion of the formation; Allowing the heat to transfer from the one or more heat sources to a selected section of the formation; Maintaining a pressure of the selected section above atmospheric pressure to increase a partial pressure of H2, as compared to the partial pressure of H2 at atmospheric pressure, in at least a majority of the selected section; and Producing a mixture from the formation. The produced mixture of the above method comprises condensable hydrocarbons having an API gravity of at least about 25 deg. (62) Divided Out of 522139
Patent NZ-537209-A (NZ)
Title: Propionic acid derivatives and their use as HPPARS activators
Inventor: BESWICK PAUL
IPC: C07C323/25
Filed: 2003-06-18
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt, solvate, or hydrolysable ester thereof. Wherein:R1 and R2 are independently hydrogen or C1-3 alkyl;X represents a bond, CH2 or O;R3 and R4 are independently hydrogen, C1-6 alkyl, OCH3, CF3, allyl or halogen;X1 is CH2, SO2, or CO;R5 is -C1-6 alkyl (optionally substituted by C1-6alkoxy or C1-6alkylthio), -C2-6 alkenyl, -C0-6 alkyl phenyl (wherein the phenyl is optionally substituted by one or more CF3, halogen, C1-3 alkyl, C1-3 alkoxy), -COC1-6 alkyl, SO2C1-6 alkyl; R6 is phenyl or a 6 membered heteroaryl group containing 1,2 or 3 N atoms wherein the phenyl or heteroaryl group is optionally substituted with 1, 2 or 3 moieties selected from the group consisting of C1-6 alkyl, halogen, -OC1-6 alkyl, -SO2C1-3 alkyl, phenyl (optionally substituted by one or more groups selected from halogen, CF3, C1-3 alkyl, OC1-3 alkyl, acetyl, CN).
Patent NZ-539035-A (NZ)
Title: Orbital sander with vertical handle
Inventor: COOPER VINCENT P
IPC: B24B23/03
Filed: 2005-03-24
Abstract: An orbital sander (10) having a housing defining an axis (13). A motor (14) and output with a sanding element are aligned on said axis (13). The housing (12) includes a power source (28) as well as an activating member (30) to energize and de-energize the sander (10). A handle (26) is spaced from the housing (12) and is substantially parallel to the axis (13). Further, additional gripping members (22,24) may be positioned on the housing (12) to provide multiple gripping surfaces.
Patent NZ-541404-A (NZ)
Title: Antibody or antigen-binding fragment thereof that binds to KIM-1, or a polypeptide comprising a KIM-I immunoglobulin domain to treat autoimmune diseases
Inventor: RENNERT PAUL D
IPC: A61K38/00
Filed: 2003-12-29
Abstract: The use of KIM-1 antagonists to inhibit signaling between a T cell and a second cell, e.g., an antigen-presenting cell, is disclosed. Such inhibition is useful for treatment of diseases including various autoimmune diseases and graft-versus-host disease. Also disclosed is the use of a KIM-1 antagonist to inhibit secretion of IFN-gamma by lymphocytes or other immune cells in a mammal. Inhibition of IFN-gamma is useful for treatment of inflammatory diseases or disorders, e.g., inflammatory bowel disease.
Patent NZ-543986-A (NZ)
Title: Fluid mixing device having movable disk with plurality of sets of apertures
Inventor: BILLINGTON ROGER JAMES
Filed: 2005-12-07
Abstract: A fluid control device (10) for mixing of fluids, suited for delivery of water at controlled temperature and flow rate, is disclosed. The device has first and second fluid inlets and an outlet for delivery of a resultant mixture at controlled parameters. The fluid control device includes a stationary disk (21) and a moveable disk (23) in contact with the stationary disk, where the moveable disk has a plurality of sets of apertures for flow through the disks of the first and second fluids to a mixing chamber (24) and a set of plurality of apertures for flow of mixed fluid through the disks to the outlet. A moving means provides selective movement of the moveable disk to control the flow of fluid.
Patent NZ-546670-A (NZ)
Title: Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
IPC: A61K48/00
Filed: 2000-11-03
Abstract: A composition suitable for use in gene therapy comprising a vector containing a transgene which encodes an angiogenic protein or petide which is selected from a hypoxia-inducable factor, an angiopoietin, a nitric oxide synthase, a hepatocyte growth factor, or a multi-finger zinc-binding protein that induces the expression of an endogenous angiogenic gene.
Patent NZ-548392-A (NZ)
Title: A package dispensing carton with a tear line defining a dispenser flap that connects tear lines in the first and second side end flaps
Inventor: GOMES JEAN-MANUEL
IPC: B65D71/36
Filed: 2005-02-11
Abstract: An enclosed carton 181 for carrying a plurality of cylindrical containers, each with a diameter, in at least two rows including a bottom row, the carton 181 having two ends, at least one of which is an exiting end capable of permitting containers to exit the carton 181 one at a time, the carton 181 comprising a bottom panel, a top panel 118, a foldably attached top end flap, foldably attached adjoining side panels 114, and means to close any end that is a non-exiting end, the exiting end 138 having a bottom tear line 168 that extends at least partially across the exiting end 138, and side tear lines 162 extending from the bottom tear line 168 to form an end retainer 182 in the exiting end adjacent to each side panel 114, each side tear line 162 extending into and across the adjacent side panel 114 and into the top panel 118 where the side tear lines 162 meet, with all of the tear lines being interconnected to form a dispenser at a distance BH from the bottom panel at least sufficient to restrain the containers in the bottom row from rolling out when the dispenser is open, wherein the tear lines form a dispenser flap that when removed forms a dispenser opening, the bottom tear line 168 being spaced at a distance from the bottom panel at least sufficient to restrain the containers in the bottom row from rolling out when the dispenser is open, and at least the exiting end of the carton 181 has four flaps for closing the end of the carton 181, with a bottom end flap 130 foldably attached to the bottom panel, a top end flap 142 foldably attached to the top panel 118, a side end flap 146 foldably attached to each adjoining side panel 114, and means for attaching the flaps together to close the end of the carton 181.
Patent NZ-550983-A (NZ)
Title: Fused quinoline derivative and use as an NK2 receptor antagonist
Inventor: KAJINO MASAHIRO
IPC: B60K7/00
Filed: 2005-04-28
Abstract: Disclosed is a compound of formula (I), or a salt thereof, wherein the substituents are as defined in the specification. Also disclosed is a method of producing the above compound, and its use as an NK2 receptor antagonist to treat functional gastrointestinal diseases such as irritable bowel syndrome or nonulcer dyspepsia.